aclacinomycin has been researched along with Di Guglielmo Disease in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 8 (88.89) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aries, A; Jardillier, JC; Jeannesson, P; Morceau, F; Nyoung, MN; Ottolenghi, S; Ronchi, A; Trentesaux, C | 1 |
| Aries, A; Devy, L; Jardillier, JC; Jeannesson, P; Lahlil, R; Morceau, F; Trentesaux, C | 1 |
| Aries, A; Doubeikovski, A; Jardillier, JC; Jeannesson, P; Ottolenghi, S; Trentesaux, C | 1 |
| Aries, A; Chenais, B; Devy, L; Gillet, R; Jeannesson, P; Lahlil, R; Morceau, F; Trentesaux, C | 1 |
| Benoist, H; Broglio, C; Desplaces, A; Dufer, J; Idoine, O; Jeannesson, P; Joly, P | 1 |
| Garnier-Suillerot, A; Tarasiuk, J | 1 |
| Jacquot, R; Jardillier, JC; Jeannesson, P; Mayeux, P; Nyoung, MN; Trentesaux, C | 1 |
| Robinson, SH; Tsamadou, AI; Tsiftsoglou, AS; Wong, W | 1 |
| Benoist, H; Carpentier, Y; Comoe, L; Desplaces, A; Dufer, J; Joly, P | 1 |
1 review(s) available for aclacinomycin and Di Guglielmo Disease
| Article | Year |
|---|---|
Anthracyclines as tumor cell differentiating agents: effects on the regulation of erythroid gene expression.
Topics: Aclarubicin; Antibiotics, Antineoplastic; Carbohydrate Sequence; Cell Differentiation; Doxorubicin; Erythroid Precursor Cells; Gene Expression Regulation, Leukemic; Humans; Leukemia, Erythroblastic, Acute; Leukemia, Myeloid; Molecular Sequence Data | 1997 |
8 other study(ies) available for aclacinomycin and Di Guglielmo Disease
| Article | Year |
|---|---|
Increased expression of GATA-1 and NFE-2 erythroid-specific transcription factors during aclacinomycin-mediated differentiation of human erythroleukemic cells.
Topics: Aclarubicin; Adjuvants, Immunologic; Base Sequence; Binding Sites; Cell Differentiation; DNA Probes; DNA-Binding Proteins; Erythroid-Specific DNA-Binding Factors; GATA1 Transcription Factor; Gene Expression; Globins; HeLa Cells; Humans; Hydroxymethylbilane Synthase; Leukemia, Erythroblastic, Acute; Molecular Sequence Data; Promoter Regions, Genetic; RNA, Messenger; Sensitivity and Specificity; Transcription Factors | 1993 |
Evidence for distinct regulation processes in the aclacinomycin- and doxorubicin-mediated differentiation of human erythroleukemic cells.
Topics: Aclarubicin; Antibiotics, Antineoplastic; Base Sequence; Cell Differentiation; DNA-Binding Proteins; Doxorubicin; Erythroid-Specific DNA-Binding Factors; GATA1 Transcription Factor; Gene Expression; Globins; Hemoglobins; Humans; Hydroxymethylbilane Synthase; Leukemia, Erythroblastic, Acute; Molecular Sequence Data; NF-E2 Transcription Factor; NF-E2 Transcription Factor, p45 Subunit; Receptors, Erythropoietin; RNA, Messenger; Transcription Factors; Tumor Cells, Cultured | 1996 |
Activation of erythroid-specific promoters during anthracycline-induced differentiation of K562 cells.
Topics: Aclarubicin; Antibiotics, Antineoplastic; Base Sequence; Cell Differentiation; Doxorubicin; Erythropoiesis; Humans; Leukemia, Erythroblastic, Acute; Molecular Sequence Data; Promoter Regions, Genetic; Tumor Cells, Cultured | 1996 |
Studies on the susceptibility to NK-mediated lysis and the simultaneous expression of various surface molecules in anthracyclin-treated K562 cells and in four K562 cell clones.
Topics: Aclarubicin; Antibiotics, Antineoplastic; Antigens, CD; Antigens, Surface; Cell Adhesion Molecules; Clone Cells; Cytotoxicity, Immunologic; Flow Cytometry; Glycophorins; Histocompatibility Antigens Class I; Humans; Killer Cells, Natural; Leukemia, Erythroblastic, Acute; Lewis X Antigen; Receptors, IgG; Receptors, Transferrin; Rosette Formation; Tumor Cells, Cultured | 1992 |
Kinetic parameters for the uptake of anthracycline by drug-resistant and drug-sensitive K562 cells.
Topics: Aclarubicin; Biological Transport; Cell Line; Cell Membrane; Doxorubicin; Drug Resistance; Fluorescence Polarization; Kinetics; Leukemia, Erythroblastic, Acute; Membrane Fluidity; Temperature | 1992 |
Induction of erythropoietin receptors during aclacinomycin-mediated erythroid differentiation of K562 leukemia cells.
Topics: Aclarubicin; Adjuvants, Immunologic; Binding Sites; Cell Differentiation; Erythroid Precursor Cells; Erythropoietin; Hemoglobins; Humans; Leukemia, Erythroblastic, Acute; Receptors, Cell Surface; Receptors, Erythropoietin | 1991 |
Cooperative effects of hemin and anthracyclines in promoting terminal erythroid maturation in K562 human erythroleukemia cells.
Topics: Aclarubicin; Benzidines; Cell Differentiation; Drug Synergism; Erythroid Precursor Cells; Hemin; Hemoglobins; Humans; Leukemia, Erythroblastic, Acute; Tumor Cells, Cultured | 1991 |
Comparative effects of fagaronine, adriamycin and aclacinomycin on K562 cell sensitivity to natural-killer-mediated lysis. Lack of agreement between alteration of transferrin receptor and CD15 antigen expressions and induction of resistance to natural kil
Topics: Aclarubicin; Alkaloids; Antigens, CD; Antineoplastic Agents; Benzophenanthridines; Cell Line; Cytotoxicity, Immunologic; Doxorubicin; Glycophorins; Hemoglobins; Humans; Immunity, Innate; Killer Cells, Natural; Leukemia, Erythroblastic, Acute; Phenanthridines; Receptors, Transferrin; Tumor Cells, Cultured | 1989 |